Tempest Therapeutics, Inc. (OVAS) [Rocket]

In millions, except per share items	Jun-30-23	Mar-31-23	Dec-31-22	Sep-30-22	Jun-30-22	Mar-31-22	Dec-31-21	Sep-30-21
	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q
Net income	-7.6	-7.6	-9.1	-8.9	-9.2	-8.5	-7.8	-8.1
Depreciation and amortization [+]	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1
Depreciation	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1
Stock-based compensation	0.4	0.4	0.4	0.4	0.4	0.3	0.3	0.3
Change in working capital [+]	0.4	-1.2	10.4	-0.7	0.3	0.9	8.5	-4.3
Other current assets	0.4	0.0	1.3	-0.8	0.3	0.2	-0.4	-0.8
Accounts payable	-0.3	0.0	0.1	-0.5	0.8	-0.3	-1.3	-4.3
Accrued expenses	0.3	-1.2	0.8	0.6	-0.7	1.1	1.1	0.8
Other	0.0	0.0	8.3	0.0	0.0	0.0	9.2
Other operating activities	0.2	0.0	-8.4	-0.1	0.0	0.0	-9.1	0.2
Cash from operations	-6.4	-8.3	-6.5	-9.1	-8.4	-7.1	-8.0	-11.8

Capital expenditures	-0.1	0.0	-0.4	-0.1	-0.1	0.0	0.0	0.0
Purchases of property and equipment	-0.1	0.0	-0.4	-0.1	-0.1	0.0	0.0	0.0
Other cash from investing								0.0
Cash from investing	-0.1	0.0	-0.4	-0.1	-0.1	0.0	0.0	0.0

Issuance of common stock, net	1.2	0.0	0.0	0.4	7.1	1.4	0.0	3.5
Option exercises							0.0	0.0
Financing costs							0.0
Other cash from financing			-4.7	0.0	7.3		0.1	-0.2
Cash from financing	1.2	0.0	-4.7	0.4	14.4	1.4	0.0	3.2

Free cash flow	-6.5	-8.3	-6.8	-9.2	-8.5	-7.1	-8.0	-11.8
Per share (diluted)	($0.46)	($0.61)	($0.59)	($0.67)	($0.74)	($0.99)	($2.11)	($1.76)

Cash paid for interest	0.3	0.3	0.6	0.3	0.3	0.3	0.3	0.3
Cash paid for income taxes	0.1	0.0